Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Post by Tumbleweed67on Jul 21, 2010 1:14am

1309 Views

Post# 17283870

WHO IS THIS? (WOW!)

Stem Cell Therapeutics Corp. (SSS)						As of July 20th, 2010
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Jul 20/10	Jul 20/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	25,000	.055
Jul 20/10	Jul 16/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	44,000	.055
Jul 20/10	Jul 15/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	31,000	.055
Jul 20/10	Jul 14/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	44,000	.055
Jul 20/10	Jul 13/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	331,000	.055
Jul 20/10	Jul 12/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	109,000	.055
Jul 20/10	Jul 09/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	10 - Acquisition in the public market	703,000	.055
Jul 20/10	Jul 09/10	Peterson, Ronald Dean	Indirect Ownership	Common Shares	00 - Opening Balance-Initial SEDI Report
Jul 20/10	Jul 09/10	Peterson, Ronald Dean	Direct Ownership	Common Shares	00 - Opening Balance-Initial SEDI Report